This could be biologically plausible if prostate cancers in men with the adrenal-permissive HSD3B1 genotype are more (nongonadal) androgen dependent compared with adrenal-restrictive HSD3B1 tumors, with the latter having a decreased capacity to use and depend on extragonadal androgens. This evidence concerns the gene HSD3B1 and Familial prostate cancer.